REGENXBIO Inc. (RGNX) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
REGENXBIO Inc. (Stock Symbol: RGNX) is a leading company in the Life Sciences sector , specifically operating within the Biological Products, (No Diagnostic Substances) industry. The organization employs approximately 408 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Annual Revenue: $155 million generating a -180.4% net profit margin .
Market Capitalization: $463 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): 16.3% - Excellent shareholder return efficiency, indicating strong management effectiveness.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for REGENXBIO Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
REGENXBIO Inc. strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company demonstrates robust operational efficiency through strong free cash flow generation of $143 million annually . The company maintains a healthy 16.4% gross margin, indicating strong pricing power and operational efficiency.